๐๏ธ OncologyInjection (IV)
Lynozyfic
Linvoseltamab
BCMA-directed bispecific antibody for relapsed/refractory multiple myeloma after at least 4 prior lines of therapy.
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Lynozyfic used for?
- Relapsed/refractory multiple myeloma
02
Linvoseltamab side effects
The following side effects have been reported for Linvoseltamab. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Infections
Neutropenia
Anemia
Neurotoxicity
03
Linvoseltamab warnings & precautions
- Black box: CRS and ICANS. Step-up dosing and REMS required
- Serious infections possible
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Lynozyfic in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.